Pfizer Extends Partnership With Israeli Drug Development Firm CytoReason
CytoReason built a machine learning platform that can quantify a person’s immune system in order to better understand disease responses.
February 15, 2022
Israeli Scientists Aim To Mobilize Allergy-Causing Cells To Fight Cancer
Tumors in mice lost half their size when injected with eosinophils, best known for inducing allergies; promising results also seen in human tumor cells in vitro.
September 27, 2021
Biotech Startup Immunai Raises $60M To Fuel Growth Of Drug Discovery Platform
Founded in 2018, Immunai is on a mission to map out the immune system to improve immunotherapies and discover new treatments.
February 16, 2021
Israeli Startup Nucleai Raises $6.5M For Its AI Precision Oncology System
Founded in 2017, Nucleai developed a platform that leverages tissue datasets to produce insights into cancer biology, increase clinical trial efficacy and improve patient care.
July 08, 2020
Israeli Cancer Treatment Company Kahr Medical Raises $18M
The company aims to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107.
February 27, 2020
Israel’s NeoTx Raises $45M For Cancer Immunotherapy Treatment
The Rehovot-based company uses its Selective T cell Redirection (STR) platform to develop targeted anticancer immunotherapies.
February 20, 2020
Israel’s Sheba Hospital To Use Pods To Grow Cancer-Killing Cells
The Ramat Gan medical center hospital will test and refine the Cocoon system developed by Switzerland’s Lonza Group to fast-track production of CAR-T immunotherapy.
March 19, 2019